Patents Examined by Michael D'Angelo
  • Patent number: 9075511
    Abstract: User interfaces for medical perfusion systems that provide oxygenation, filleting, and recirculation of blood in connection with various medical procedures are provided. In particular, methods of displaying and communicating a desired target flow rate and cardiac index during cardiopulmonary bypass surgeries are provided.
    Type: Grant
    Filed: January 25, 2013
    Date of Patent: July 7, 2015
    Assignee: Medtronic, Inc.
    Inventors: Brian J. Steffens, Mark Salzwedel, Mark G. Bearss, Keith D. Rohde
  • Patent number: 9072433
    Abstract: Embodiments of the present disclosure relate to a system and method for determining a physiologic parameter of a patient. Specifically, embodiments provided herein include blood pressure cuffs that are adapted to be used in conjunction with a photoplethysmography sensor. The cuff as provided may be configured to be placed over the sensor and/or aligned in a specific manner relative to the sensor. Alternatively, the cuffs may include integral optical components.
    Type: Grant
    Filed: February 18, 2011
    Date of Patent: July 7, 2015
    Assignee: COVIDIEN LP
    Inventors: Bo Chen, Youzhi Li, Daniel Lisogurski
  • Patent number: 9072476
    Abstract: A flexible mounting base to hold a sensor at an infusion site, the sensor being a removable in vivo sensor for monitoring analyte concentration level in a patient, such as blood glucose (BG) level. The mounting base comprises a flexible adhesive that anchors the flexible sensor set at an infusion site to provide stability for the sensor set in a convenient and comfortable manner. Placement of the mounting base onto the patient's skin causes the insertion needle to pierce the skin for transcutaneous placement of the cannula with the sensor therein. The insertion needle can then be withdrawn to leave the cannula and sensor at the selected insertion position, with the distal segment of the sensor being exposed to patient extracellular fluid via apertures formed in the cannula.
    Type: Grant
    Filed: September 23, 2005
    Date of Patent: July 7, 2015
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Rajiv Shah, Rebecca K. Gottlieb, Eric A. Larson
  • Patent number: 9060697
    Abstract: A blood pressure meter cuff includes an air bladder that receives a supply of air in order to compress a radial artery and an ulnar artery, and a cuff band for fixing the air bladder to a wrist including the radial artery and the ulnar artery. The air bladder has a wide portion that is arranged on the radial artery and the ulnar artery, and first and second narrow portions that are continuous with the wide portion and are narrower than the wide portion. The edges of the first and second narrow portions that are continuous with the edges of the wide portion are shaped as straight lines that are inclined with respect to the width direction.
    Type: Grant
    Filed: April 3, 2013
    Date of Patent: June 23, 2015
    Assignee: OMRON HEALTHCARE Co., Ltd.
    Inventors: Chisato Uesaka, Takanori Nishioka, Ryosuke Doi, Shingo Yamashita, Yukiya Sawanoi
  • Patent number: 9055901
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: June 16, 2015
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Daniel Kline, Steve Masterson, Sean Saint
  • Patent number: 9050041
    Abstract: Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: June 9, 2015
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
  • Patent number: 9049998
    Abstract: A biometric monitoring device measuring various biometric information is provided that allows the person to take and/or display a heart rate reading by a simple user interaction with the device, e.g., by simply touching a heart rate sensor surface area or moving the device in a defined motion pattern. Some embodiments of this disclosure provide biometric monitoring devices that allow a person to get a quick heart rate reading without removing the device or interrupting their other activities. Some embodiments provide heart rate monitoring with other desirable features such as feedback on data acquisition status.
    Type: Grant
    Filed: January 13, 2014
    Date of Patent: June 9, 2015
    Assignee: Fitbit, Inc.
    Inventors: Christine Boomer Brumback, Nicholas Adrian Myers, Shelten Gee Jao Yuen, James Park, Todd Sutham Diemer
  • Patent number: 9049995
    Abstract: Techniques are provided for detecting pulmonary congestion based on an increase in right ventricular (RV) stroke volume over left ventricular (LV) stroke volume. In one example, the device generates an index based on accumulated differences between RV stroke volume and LV stroke volume while RV stroke volume exceeds LV stroke volume, such that the index is indicative of an ongoing imbalance between RV and LV stroke volume. The index is compared to a suitable threshold to detect a severe imbalance indicative of pulmonary edema. Additionally, techniques are described for estimating RV and LV stroke volumes based on pulmonary artery pressure, left atrial pressure, aortic pressure, LV strain or on various intracardiac or extracardiac impedance measurements.
    Type: Grant
    Filed: January 12, 2012
    Date of Patent: June 9, 2015
    Assignee: PACESETTER, INC.
    Inventors: Andreas Blomqvist, Alex Soriano
  • Patent number: 9044150
    Abstract: A biometric monitoring device having a heart rate sensor for measuring various biometric information is provided. In some embodiments, the biometric monitoring device allows the person to take and/or display a heart rate reading by a simple user interaction with the device, e.g., by simply touching a heart rate sensor surface area, moving the device in a defined motion pattern, or clenching the fist. Some embodiments of this disclosure provide a biometric monitoring device that allows a person to get a quick heart rate reading without removing the device or interrupting their other activities. Some embodiments provide heart rate monitoring with other desirable features such as feedback on data acquisition status.
    Type: Grant
    Filed: September 11, 2014
    Date of Patent: June 2, 2015
    Assignee: Fitbit, Inc.
    Inventors: Christine Boomer Brumback, Nicholas Adrian Myers, Shelten Gee Jao Yuen, James Park, Todd Sutham Diemer
  • Patent number: 9042974
    Abstract: A method and system for treating brain disorders comprises detecting activity of a first target area of the brain via a first implanted sensor and determining the presence of target brain activity by analyzing the detected brain activity in combination with treating the user based upon the determined presence of target brain activity by supplying a first therapeutic agent to the first target area via a first implanted fluid delivery member including at least one distal opening adjacent to the first target area. In addition, the system may be used as well for testing the effectiveness of drugs.
    Type: Grant
    Filed: September 12, 2005
    Date of Patent: May 26, 2015
    Assignee: NEW YORK UNIVERSITY
    Inventors: Nandor Ludvig, Lorant Kovacs, Ruben Kuzniecky, Orrin Devinsky, Werner Doyle, Walter Blumenfeld, Geza Medveczky
  • Patent number: 9039627
    Abstract: A monitoring device for monitoring the vital signs of a user is disclosed herein. The monitoring device is preferably comprises an article, an optical sensor, an accelerometer and processor. The optical sensor preferably comprises a photodetector and a plurality of light emitting diodes. A sensor signal from the optical sensor is processed with a filtered accelerometer output signal from the accelerometer to create a filtered vital sign signal used to generate a real-time vital sign for a user.
    Type: Grant
    Filed: February 24, 2013
    Date of Patent: May 26, 2015
    Assignee: Impact Sports Technologies, Inc.
    Inventors: Nikolai Rulkov, Mark Hunt, Donald Bradu
  • Patent number: 9042954
    Abstract: Generally, embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have improved signal response and stability by inclusion of a coating including a hydrogel, a crosslinker, and a swelling modulator, where the coating is disposed proximate to a working electrode of in vivo and/or in vitro analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
    Type: Grant
    Filed: November 24, 2009
    Date of Patent: May 26, 2015
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Balasubrahmanya S. Bommakanti, Gary Sandhu, Udo Hoss
  • Patent number: 9033877
    Abstract: A device is provided for determining blood glucose characteristics including a display configured for presenting a graphical representation of a plurality of measurements of blood glucose values, wherein the graphical representation comprises a trend indicator indicating an approximate value trend in the sensed blood glucose value over a recent series of measurements, based on graphical segments having different graphical styles assigned to different ranges of sensed blood glucose values to indicate a transition from a first range to a second range of sensed blood glucose values. An associated method for operating a device for determining blood glucose characteristics is also provided.
    Type: Grant
    Filed: February 23, 2011
    Date of Patent: May 19, 2015
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Karl Werner, Peter Blasberg
  • Patent number: 9037210
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: May 19, 2015
    Assignee: DEXCOM, INC.
    Inventors: Peter C. Simpson, Mark Brister, Jacob S. Leach
  • Patent number: 9028422
    Abstract: A patient monitor is disclosed for detecting patient movement or abnormal breathing. Images of a patient are obtained by a stereoscopic camera. These images are then processed by a 3D position determination module which determines measurements indicative of positions of at least part of a patient. The obtained measurements are then passed to a model generation module which generates a breathing model of the variation in position of the at least part of a patient during a breathing cycle. Subsequently abnormal breathing or patient movement can be detected by processing further images obtained by the stereoscopic camera to determine more measurements indicative of positions of at least part of a patient. These measurements are then compared with a stored breathing model by a comparison module.
    Type: Grant
    Filed: February 12, 2009
    Date of Patent: May 12, 2015
    Assignee: Vision RT Limited
    Inventors: Ivan Daniel Meir, Norman Ronald Smith, Anthony Christopher Ruto
  • Patent number: 9028418
    Abstract: A noninvasive method for measuring systolic blood pressure Psyst, by applying and maintaining an astringent emptying pressure P1, which is above the systolic blood pressure Psyst, on a first zone of the finger located in the vicinity of the distal part of the finger, applying and maintaining an astringent occluding pressure P2, which is above the systolic blood pressure Psyst, on a second zone of the finger located upstream of the first zone, releasing the emptying pressure P1, releasing the occluding pressure P2 in a controlled manner, and, at the same time, acquiring at least the occluding pressure P2 and at least the blood volume Vs, at the level of the first zone as a function of time, and calculating the systolic blood pressure Psystcorresponding to the occluding pressure P2 at the moment of blood return in the finger, characterized by a substantially positive variation in the blood volume Vsof the finger at the level of the first zone.
    Type: Grant
    Filed: December 3, 2009
    Date of Patent: May 12, 2015
    Assignee: ATYS SARL
    Inventors: Denis Parzy, Benoit Guibert
  • Patent number: 9028409
    Abstract: One or more therapeutic fluids, such as for example insulin can be delivered to a body. In addition or alternatively, the concentrations of one or more analytes can be measured in vivo. A feedback process can be used to regulate levels of the one or more analytes based on the measurements via delivery of the one or more therapeutic fluids. Related systems, apparatus, methods, and/or articles are also described.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: May 12, 2015
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Ofer Yodfat, Gavriel J. Iddan, Ruthy Kaidar, Gali Shapira
  • Patent number: 9022932
    Abstract: A method and an apparatus for measuring glucose level in the body fluid of a subject, typically blood glucose level, by measuring impedance of a body tissue, with two pairs of electrodes, two electrodes for injecting current into a body tissue and two electrodes for detecting the ensuing voltage of the body tissue. The body tissue is typically a sub-dermal or sub-cutaneous tissue. The measured impedance of the body tissue is used to correlate with directly determined glucose levels to determine the glucose level from the measured impedance. It is thus possible to determine body fluid glucose levels in a reliable and reproducible manner.
    Type: Grant
    Filed: February 4, 2005
    Date of Patent: May 5, 2015
    Assignee: Dermal Devices, Inc.
    Inventors: Stig Ollmar, Peter Aberg, Ulrik Birgersson, Fredrik Neiderud
  • Patent number: 9022942
    Abstract: Disclosed herein is a system for monitoring a patient that includes a cuff configured to inflate to at least partially occlude an artery of the patient and a cuff controller configured to control inflation and deflation of the cuff. The system also includes a sensor configured to receive a signal associated with the at least partially occluded artery and generate an output signal based on the received signal. Also included is a signal analysis module configured to receive the output signal and determine a first hemodynamic parameter based on a first set of data obtained during inflation of the cuff and a second set of data obtained during deflation of the cuff.
    Type: Grant
    Filed: May 15, 2012
    Date of Patent: May 5, 2015
    Assignee: Welch Allyn, Inc.
    Inventors: David E. Quinn, Matt Kinsley, Tyson B. Whitaker, John D. Seller
  • Patent number: 9020572
    Abstract: Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.
    Type: Grant
    Filed: September 10, 2010
    Date of Patent: April 28, 2015
    Assignee: DexCom, Inc.
    Inventors: Michael Robert Mensinger, John Michael Dobbles, Apurv U. Kamath, Beat Stadelmann, Deborah M. Ruppert, Nasser Salamati, Richard C. Yang